Expression and in vitro function of anti-PD-L1 human antibody expressed in plant

被引:5
作者
Lee, Chae Eun [1 ]
Lee, Jeong Hwan [1 ]
Chung, Hyun Joo [1 ]
Lee, Da Won [1 ]
Lim, Jong Seok [1 ]
Kim, Kibum [3 ]
Kim, Jin Wook [4 ,5 ]
Lee, Yong Seong [4 ]
Kim, Kyung Soo [6 ]
Min, Hyun Jin [6 ]
Ko, Kisung [2 ,3 ]
Myung, Soon Chul [1 ,2 ]
机构
[1] Chung Ang Univ, Coll Med, Dept Urol, Seoul, South Korea
[2] Chung Ang Univ, Mol Biodesign Res Ctr, Seoul, South Korea
[3] Chung Ang Univ, Coll Med, Dept Med, Therapeut Prot Engn Lab, Seoul, South Korea
[4] Chung Ang Univ, Dept Urol, Gwangmyeong Hosp, Gyeonggi Do, South Korea
[5] Chung Ang Univ, Coll Med, Dept Med Informat, Seoul, South Korea
[6] Chung Ang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Anti-PD-L1; antibodies; Avelumab; Immune system; Plant expression system; Therapeutic protein; VACCINES;
D O I
10.1007/s11816-023-00844-7
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Plants can be used to produce recombinant functional proteins such as antibodies and vaccines. In this study, transgenic plants were utilized to express anti-human programmed death ligand-1 (PD-L1) monoclonal antibodies (mAb(P) PD-L1) tagged with the endoplasmic reticulum retention motif KDEL. PCR and immunoblot analyses confirmed that mAb PD-L1 was expressed in transgenic plants. ELISA analysis confirmed the binding activity of mAb(P) PD-L1 to human prostate and urothelial cancer cell lines PC-3 and TCCSUP, respectively. Confocal imaging analysis demonstrated that mAb(P) PD-L1 had binding activity against human cancer cell lines similar to Avelumab (mAb(M) PD-L1). Confocal imaging analysis showed that the binding activity of mAb(P) PD-L1 to the human tonsil is comparable to mAb(M) PD-L1. These results suggest that mAb(P) PD-L1 shows functional binding activities for PD-L1(+) cancer cells. Hence, this study showed that tobacco plants can be used to produce functional anti-human PD-L1 mAbs.
引用
收藏
页码:531 / 539
页数:9
相关论文
共 25 条
[1]   PD-L1 Glycosylation and Its Impact on Binding to Clinical Antibodies [J].
Benicky, Julius ;
Sanda, Miloslav ;
Kennedy, Zuzana Brnakova ;
Grant, Oliver C. ;
Woods, Robert J. ;
Zwart, Alan ;
Goldman, Radoslav .
JOURNAL OF PROTEOME RESEARCH, 2021, 20 (01) :485-497
[2]   Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells [J].
Boyerinas, Benjamin ;
Jochems, Caroline ;
Fantini, Massimo ;
Heery, Christopher R. ;
Gulley, James L. ;
Tsang, Kwong Yok ;
Schlom, Jeffrey .
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10) :1148-1157
[3]   PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma [J].
Chen, Chang-Long ;
Pan, Qiu-Zhong ;
Zhao, Jing-Jing ;
Wang, Ying ;
Li, Yong-Qiang ;
Wang, Qi-Jing ;
Pan, Ke ;
Weng, De-Sheng ;
Jiang, Shan-Shan ;
Tang, Yan ;
Zhang, Xiao-Fei ;
Zhang, Hong-Xia ;
Zhou, Zi-Qi ;
Zeng, Yi-Xin ;
Xia, Jian-Chuan .
ONCOIMMUNOLOGY, 2016, 5 (07)
[4]   Steroidogenic effects of Taraxacum officinale extract on the levels of steroidogenic enzymes in mouse Leydig cells [J].
Chung, Hyun Joo ;
Noh, Yoohun ;
Kim, Min Su ;
Jang, Ara ;
Lee, Chae Eun ;
Myung, Soon Chul .
ANIMAL CELLS AND SYSTEMS, 2018, 22 (06) :407-414
[5]   IMPROVED HIGH-LEVEL CONSTITUTIVE FOREIGN GENE-EXPRESSION IN PLANTS USING AN AMV RNA4 UNTRANSLATED LEADER SEQUENCE [J].
DATLA, RSS ;
BEKKAOUI, F ;
HAMMERLINDL, JK ;
PILATE, G ;
DUNSTAN, DI ;
CROSBY, WL .
PLANT SCIENCE, 1993, 94 (1-2) :139-149
[6]   The intracellular signalosome of PD-L1 in cancer cells [J].
Escors, David ;
Gato-Canas, Maria ;
Zuazo, Miren ;
Arasanz, Hugo ;
Jesus Garcia-Granda, Maria ;
Vera, Ruth ;
Kochan, Grazyna .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2018, 3
[7]   Taliglucerase alfa: An enzyme replacement therapy using plant cell expression technology [J].
Grabowski, Gregory A. ;
Golembo, Myriam ;
Shaaltiel, Yoseph .
MOLECULAR GENETICS AND METABOLISM, 2014, 112 (01) :1-8
[8]   An odor detection system based on automatically trained mice by relative go no-go olfactory operant conditioning [J].
He, Jing ;
Wei, JingKuan ;
Rizak, Joshua D. ;
Chen, YanMei ;
Wang, JianHong ;
Hu, XinTian ;
Ma, YuanYe .
SCIENTIFIC REPORTS, 2015, 5
[9]   Immune checkpoint: The novel target for antitumor therapy [J].
Jiang, Xianghu ;
Liu, Guohong ;
Li, Yirong ;
Pan, Yunbao .
GENES & DISEASES, 2021, 8 (01) :25-37
[10]   Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial [J].
Keilholz, Ulrich ;
Mehnert, Janice M. ;
Bauer, Sebastian ;
Bourgeois, Hugues ;
Patel, Manish R. ;
Gravenor, Donald ;
Nemunaitis, John J. ;
Taylor, Matthew H. ;
Wyrwicz, Lucjan ;
Lee, Keun-Wook ;
Kasturi, Vijay ;
Chin, Kevin ;
von Heydebreck, Anja ;
Gulley, James L. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7